天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Beijing Comparison Pharmaceutical Technology Co., Ltd??? ?? ??? ?????.

?? ?:Beijing Comparison Pharmaceutical Technology Co., Ltd
??:010-010-52878169
???:sales@bjcomparison.com
??:China
URL: www.bjcomparison.com
? ?? ?:4872
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49

?? ????

2-?????616-45-5C4H7NO
C19H17N5O2
3-?????????15371-06-9C10H9NO5
35672-52-7C15H16O
4-guanidino-N-((6-hydroxynaphthalen-2-yl)(imino)methyl)benzamide hydrochloride
1831833-38-5C12H16O4S
2-(1-((2-(1-hydroxypentyl)benzoyl)oxy)pentyl)benzoic acid1841089-56-2C24H30O5
(R)-2-(2-aminothiazol-4-yl)-N-(4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl)phenyl)amino)-2-oxoethyl)thiazol-2-yl)acetamide 2,2,2-trifluoroacetate
??????,N-(2,3-?????-1,3-???-1H-????-4-?)-6118-65-6C10H8N2O3
(S)-3-((2R,5S)-2-((S)-(4-(benzyloxy)phenyl)((4-fluorophenyl)amino)methyl)-5-(4-fluorophenyl)-5-hydroxypentanoyl)-4-phenyloxazolidin-2-one1185883-39-9C40H36F2N2O5
2-???-??-(??????)-4-?????? ?C6H7N3O3S
Ceftriaxone sodium impurity 13?????? ?????120-78-5C14H8N2S4
???,3-(4,5-????-2-????)-40055-37-6C8H8N2O
2077897-94-8C21H22N2O7S
(S)-2-(butylsulfonamido)-3-(3-chloro-4-(4-(piperidin-4-yl)butoxy)phenyl)propanoic acid hydrochloride2713130-63-1C22H35ClN2O5S
19741-14-1C15H15N7O2
(2R,4S)-4-methyl-1-(((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl) sulfonyl)-L-arginyl)piperidine-2-carboxylic acid189264-04-8C23H36N6O5S
4-((2R,6S)-6-(4-fluorophenyl)tetrahydro-2H-pyran-2-yl)phenol2280081-69-6C20H21NO4
1802246-60-1C30H27N3O9S
N-((2-(5-methyl-3-phenylisoxazol-4-yl)phenyl)sulfonyl)butyramide2304623-36-5C16H14N2O3S
2044710-49-6C10H9BrFNO3
(4-((((S)-2-amino-8-methyl-4,9-dioxo-6,7,8,9-tetrahydro-4H-pyrazino[1,2-a][1,3,5]triazin-7-yl)methyl)amino)benzoyl)-L-glutamic acid79573-48-1C20H23N7O7
135729-78-1C18H24N2O
2-amino-9-(((2-chloroallyl)oxy)methyl)-1H-purin-6(9H)-one1797982-93-4C9H10ClN5O2
79902-42-4C23H34O5
(R)-2-???-N-??-3-?????????C11H16N2O2
79952-42-4C19H28O4
C22H20O3
(1R,2R)-2-(3-((5-acetoxypentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium
???????g417714-14-8C21H20N4O4
154534-83-5C10H9ClF2N4O
(3R,5R)-7-((1S,2S,6R,8S,8aR)-8-((2,2-dimethylbutanoyl)oxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid?????,?????101314-97-0C25H41NaO6
(R)-1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2,2-dimethyl-1,2,3,4-tetrahydroisoquinolin-2-ium2480467-84-1C28H35NO7S
(1R,2R)-2-(3-((5-(acryloyloxy)pentyl)oxy)-3-oxopropyl)-1-(3,4-dimethoxy benzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium 2,2,2- trifluoroacetateC38H49NO11S
1618657-31-0C18H17FO4
?????274260-05-8C10H17N3O6S
(2S)-2-amino-5-(((2R)-1-((carboxymethyl)amino)-1-oxo-3-sulfinopropan-2-yl)amino)-5-oxopentanoic acid17297-99-3C10H17N3O8S
1075726-88-3C31H39NO9S
85-63-2C21H27NO4
P-TOLYL-PROPYNOICACID??????52188-06-4C12H12O2
????????145576-25-6C27H40O6
2-acetamido-N-benzylacrylamide86921-49-5C12H14N2O2
(3R,5R)-ethyl 7-((1S,2S,6R,8S,8aR)-8-((2,2-dimethylbutanoyl)oxy)-2,6-dimethyl-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoate?????????????????864357-87-9C27H44O6
?????????139893-43-9C25H43NO6
SiMvastatin4'-?????864357-88-0C26H40O5
6-carbamoylnaphthalen-2-yl 4-ureidobenzoate
(8S,9S,10R,11S,13S,14S,16R,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-16-yl butyrate113930-13-5C25H34O7
1-(3,5-bis(benzyloxy)phenyl)-2-(tert-butylamino)ethan-1-ol hydrochloride3,5-??????????28924-25-6C26H31NO3
(R)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate???????79952-44-6C24H36O5
Simvastatin impurity04????????476305-24-5C50H76O10
1449248-72-9C25H36O5
?????????210980-68-0C25H36O4
1-(1-((1,4-dihydropyridin-3-yl)sulfonyl)-5-(2-fluorophenyl)-1H-pyrrol-3-yl)-N-methylmethanamine2416241-98-8C17H18FN3O2S
(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxy acetyl)-6a,8a,10-trimethyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro- 1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one1040085-98-0C23H30O6
67275-31-4C25H27N9O9S2
67275-30-3C25H27N9O9S2
(2S,4S)-??????189264-03-7C23H36N6O5S
N-(2-(1-(3-hydroxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3- dioxoisoindolin-4-yl)acetamide
2",3",5"-?????-?????10302-78-0C14H18N4O8
tert-butyl 2-((4R,6S)-6-((E)-2-(4-(3-fluorophenyl)-6-isopropyl-2-(N- methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3- dioxan-4-yl)acetate
(R)-2-(4-(((2-amino-4-oxo-4,8-dihydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid?????65165-91-5C19H19N7O6
N-(2-(1-(3-ethoxy-4-hydroxyphenyl)-2-(methylsulfonyl)ethyl)-1,3- dioxoisoindolin-4-yl)acetamide1384441-38-6C21H22N2O7S
(Z)-??3-(??????????)-2-(2,4,5-??????-3-??????)??????112811-70-8C16H16F3NO4
?????? ???C18H34ClN2O8PS
(R)-2-(butylsulfonamido)-3-(4-(4-(piperidin-4-yl)butoxy)phenyl) propanoic acid158808-86-7C22H36N2O5S
5,10-?????????????C20H23N7O6
313474-58-7C25H32O5
1,2-???????????137174-25-5C25H36O6
9α-????????313474-59-8C25H33BrO6
(6aR,6bS,7S,8aS,8bS,11aR,12bR)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one14,15-???????????131918-64-4C25H32O6
(6aR,6bS,8aS,8bS,11aR,12aS,12bS)-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6b,8,8a,8b,11a,12,12a,12b-octahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxole-4,7(2H,6aH)-dione216453-74-6C25H32O6
(S)-2-(4-((((S)-5-methyl-2-(methylamino)-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzamido)pentanedioic acid
21-???????????85234-63-5C25H32O6
(4aR,4bS,5S,6aS,7aR,10aR,11aS,11bS)-5-hydroxy-7a-(hydroxymethyl)-4a,6a-dimethyl-9-propyl-4b,5,6,6a,10a,11,11a,11b,12,13-decahydrochryseno[2,3-d][1,3]dioxole-2,7(4aH,7aH)-dione16α,17-[(1RS)-Butylidenebis(oxy)]-11β-hydroxy-17-(hydroxyMethyl)-D-hoMoandrosta-1,4-diene-3,17a-dione(DiastereoMers????)1040085-99-1C25H34O6
Clindamycin Phosphate impurity 13-1887402-20-2C18H34ClN2O9PS
(5R,6S)-6-((R)-1-hydroxyethyl)-7-oxo-3-((R)-tetrahydrofuran-2-yl)-4-thia-1-azabicyclo[3.2.0]hept-2-ene-2-carboxylic acid 4-oxide
???,N-(NL-γ-????-D-?????)-128960-77-0C10H17N3O6S
???,N-(ND-γ-????-L-?????)-108457-42-7C10H17N3O6S
(E)-3-(4-((3-(1-(4-((1H-imidazol-1-yl)methyl)phenyl)-2-carboxyethyl)-1H-imidazol-3-ium-1-yl)methyl)phenyl)acrylate
(1R,1'R,2R,2'R)-2,2'-(((3-methylpentane-1,5-diyl)bis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium)1193104-80-1C60H79N2O15S+
1157981-64-0C10H7F2N3O
(1S,1'S,2S,2'S)-2,2'-((pentane-1,5-diylbis(oxy))bis(3-oxopropane-3,1- diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4- tetrahydroisoquinolin-2-ium) 2,2,2-trifluoroacetateC53H72N2O12+2
(1R,1'R,2R,2'R)-2,2'-((hexane-1,5-diylbis(oxy))bis(3-oxopropane-3,1- diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4- tetrahydroisoquinolin-2-ium) 2,2,2-trifluoroacetateC60H79N2O15S+
(1R,1'R,2R,2'R)-2,2'-((hexane-1,6-diylbis(oxy))bis(3-oxopropane-3,1-diyl))bis(1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolin-2-ium)1193104-85-6C60H79N2O15S+
sodium (R,Z)-2-((1S,2R)-1-carboxylato-2-hydroxypropyl)-5-(4- hydroxybutylidene)-2,5-dihydrothiazole-4-carboxylate130609-10-8C12H18NNaO6S
(Z)-ethyl 3-ethoxy-2-(2,4,5-trifluoro-3-methoxybenzoyl)acrylate866954-86-1C15H15F3O5
2304623-35-4C16H14N2O3S
?????A73240-07-0C25H29N9O9S2
1-(4-(4-methylpiperazin-1-yl)-2-thioxo-1,2-dihydro-3H-benzo[b][1,4] diazepin-3-ylidene)propan-2-one1902955-67-2C17H20N4OS
149490-61-9C22H30N2O5S
2077897-93-7C20H21NO6S
6-carbamimidoylnaphthalen-2-yl 4-ureidobenzoate methanesulfonate
16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49
Copyright 2019 ? ChemicalBook. All rights reserved